Diabetes is a disease in which the body either
doesn't make enough insulin or can't utilize the produced insulin.
Indiabetesblood glucose level is high. Polyuria, polydipsia, polyphagia, dry
skin and tingling sensation in hands or feet are symptoms of diabetes. There
are three types of diabetes, namely, type 1 (insulin dependent), type 2
diabetes (insulin independent) and gestational diabetes. In type 1 diabetes,
the part of pancreas is attacked by body’s immune system. By mistake, the
immune system destroys isletsin the pancreas assuming them as foreign
particles. The islets are the insulin producing cells. Causes for type 1
diabetes are diseases of the pancreas, infections and family history. In type 2
diabetes, insulin is produced in less quantity but it’s not enough to maintain
optimum blood glucose. Causes of type 2 diabetes are obesity or overweight,
ethnicity, gestational diabetes, age, sedentary lifestyle, impaired glucose
tolerance, family history and insulin resistance. Gestational diabetes develops
only during pregnancy.
Diabetes is controlled by delivering insulin or
with the help of antidiabetic drugs. Insulin is released by the beta cells in
response to the high blood glucose levels. Insulin thus allows maintenance of
blood glucose level in optimum range. In type 1-diabetes, the body no longer
produces enough insulin as beta cells are destroyed. Thus controlling the blood
sugar level is challenging aspect in management of type 1 diabetes. In such a
case smart insulin can be used. A perfect glucose control will be maintained by
smart insulin. Smart insulin or glucose responsive insulin has ability to
circulate in the body. It would respond automatically to level of blood glucose
in the body. It can turn on when it’s needed and off when it’s not needed. If
the blood glucose is higher, more insulin will be released or activated. If the
blood glucose level is lower, less insulin will be released. Smart insulin will
avoid the complications related to high and low blood sugar levels. It will
reduce the requirement of checking the blood glucose level regularly. It will
also reduce the efforts of calculating insulin doses and multiple daily
injections. Smart insulin will give confidence to type 1 diabetes
patients, that to cover their needs for the day they have enough insulin no
matter how rigorously they work, what or how stressed they are.
Browse full research report with TOC on “Smart
Insulin or Glucose Responsive Insulin Market By Type, Disease, And Delivery
Device - Global Industry Analysis And Forecast To 2025” at: http://www.crystalmarketresearch.com/report/smart-insulin-or-glucose-responsive-insulin-market
The major driving factor for the smart insulin market is increase
in diabetic population. For instance, according to IDF, in 2015, diabetes
affected 415 million people worldwide and this number is expected to reach up
to 642 million by 2040. Moreover, it was found that one in 11 adults was
suffering from diabetes. Moreover, rise in the collaboration of companies with
research institutions will further drive this market. For instance in March
2016, JDRF and Sanofi announced expansion of their joint research collaboration
to include development of glucose responsive insulin therapies for treatment of
insulin dependent diabetes. The aim of this collaboration is to design
therapeutic insulin which gets activated when blood-glucose levels rise and
deactivated when blood-glucose levels begin to go low, thus preventing
dangerous highs and lows. Moreover, technological improvements in the insulin
delivery devices will also contribute to growth of this market. Further,
insulin injections are painful and thus there is a rise in demand by people for
alternatives such as smart insulin. This demand will boost the smart insulin
market. Furthermore, smart insulin patch will serve as an opportunity for this
market. The smart insulin patch will use painless microneedles to recognize the
low oxygen environment which will be created when glucose levels rise. Further,
it will deliver insulin as required. However, more complexities are associated
in manufacturing of smart insulin which will impede the growth of smart insulin
market. Moreover, huge investment cost in developing smart insulin andstrict
regulatory requirements for approvalswill also hamper the growth of this
market.
The key strategy followed by the major companies
is acquisition to be a pioneer in this market, as smart insulin is a new market
and players are looking to gain competitive advantage. For instance, in 2016,
Eli Lilly and Company acquired Glycostasis, Inc. Glycostasis, Inc. invented a
new technology known as smart insulin. This technology will help in regulating
blood glucose level by releasing more insulin when blood glucose level is high
and less insulin when blood glucose level is low. By this acquisition, Eli
Lilly and Companywill become a pioneer in the smart insulin or glucose
responsive insulin market.
The major players inthe smart insulin or glucose
responsive insulin market are Sanofi, Novo Nordisk A/S, Juvenile Diabetes
Research Foundation Ltd., Eli Lilly and Company, and Merck & Co., Inc.
Request for TOC of Smart Insulin or Glucose Responsive Insulin
Market Research Report @ http://www.crystalmarketresearch.com/request-toc/upcoming/HC0665
Smart Insulin or Glucose
Responsive Market Segmentation:
By Type:
- Intermediate
Acting
- Short
Acting
- Premixed
Type
- Long
Acting
- Rapid
Acting
By Disease:
- Type
1 Diabetes
- Type
2 Diabetes
By Delivery Device:
- Smart
Insulin Patch or Microneedle Array Patch
- Smart
Insulin Pen
- Smart Insulin Pump
Download PDF Brochure @
http://bit.ly/2A9jvzL
About Crystal Market Research
Crystal
Market Research is a U.S. based market research and business intelligence
company. Crystal offers one stop solution for market research, business
intelligence, and consulting services to help clients make more informed
decisions. It provides both syndicated as well as customized research studies
for its customers spread across the globe. The company offers market
intelligence reports across a broad range of industries including healthcare,
chemicals & materials, technology, automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Website: http://www.crystalmarketresearch.com
No comments:
Post a Comment